Allogene Therapeutics, Inc. 401(k) Plan
Sponsored by Allogene Therapeutics, Inc. · EIN 823562771 · Plan #001
- Total assets
- $44.0M
- Net assets
- $44.0M
- Active participants
- 233
- With balances
- 386
Plan year beginning 01/01/2024 · 401(k)
Linked investment advisers
Advisory firms matched from Schedule C service providers (investment codes 26-28).
| Firm | Match | Plan year |
|---|---|---|
| Strategic Advisors Llc CRD 125882 | deterministic · 100% | 2024 |
| Morgan Stanley Smith Barney Llc CRD 149777 | deterministic · 100% | 2024 |
Service providers
Schedule C providers paid $5,000+ (large plans only).
| Provider | Services | Direct comp |
|---|---|---|
| Strategic Advisors, Inc. | Investment advisory (plan) | $12,978 |
| Morgan Stanley Smith Barney Llc | Investment advisory (participants) | $12,500 |
| Fidelity Investments Institutional | Participant loan processing, Sub-transfer agency fees, Recordkeeping fees | $10,857 |